Patents by Inventor Mark T. Hamann

Mark T. Hamann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11325919
    Abstract: Aleutianamine represents the first in a new class of pyrroloiminoquinone alkaloids possessing a highly strained multi-bridged ring system, discovered from Latrunculia (Latrunculia) austini Samaai, Kelly & Gibbons, 2006 (class Demospongiae, order Poecilosclerida, family Latrunculiidae) recovered during a NOAA deep-water exploration of the Aleutian Islands. Aleutianamine exhibited potent and selective cytotoxicity toward solid tumor cell lines including pancreatic cancer (PANC-1) with an IC50 of 25 nM and colon cancer (H116) with IC50 of 1 ?M.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: May 10, 2022
    Inventor: Mark T. Hamann
  • Publication number: 20220127280
    Abstract: Aleutianamine represents the first in a new class of pyrroloiminoquinone alkaloids possessing a highly strained multi-bridged ring system, discovered from Latrunculia (Latrunculia) austini Samaai, Kelly & Gibbons, 2006 (class Demospongiae, order Poecilosclerida, family Latrunculiidae) recovered during a NOAA deep-water exploration of the Aleutian Islands. Aleutianamine exhibited potent and selective cytotoxicity toward solid tumor cell lines including pancreatic cancer (PANC-1) with an IC50 of 25 nM and colon cancer (H116) with IC50 of 1 ?M.
    Type: Application
    Filed: January 9, 2020
    Publication date: April 28, 2022
    Inventor: Mark T. Hamann
  • Patent number: 11272657
    Abstract: A strand trimmer and method of use thereof. The strand trimmer includes a pair of pivotable arms each having a motor, a follower wheel, and a cutter-spindle assembly disposed thereon. The arms are biased toward one another and are guided by the follower wheels to pivot around obstacles passing between the arms. The motor rotates the cutter-spindle assembly to move cutting strands extending therefrom through a cutting path with sufficient rotational velocity to cut vegetation. The cutter-spindle assembly includes a reloadable spool and a strand-feed mechanism. The strand-feed mechanism includes a solenoid actuated plunger within a shaft of the cutter-spindle assembly which operates to non-contactingly actuate the plunger to feed out a length of strand. The solenoid is non-rotatably carried on the trimmer arm while the shaft of the cutter-spindle assembly is encircled by and rotated within the solenoid.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: March 15, 2022
    Assignee: Trimverse LLC
    Inventors: Robert Simmons, Mark T. Hamann, Royce M. Peters
  • Publication number: 20210244725
    Abstract: Described herein are methods and systems for using an alkaloid, such as manzamine A, for anti-proliferative effects at relatively low and non-cytotoxic concentrations (up to 4 ?M) wherein manzamine A blocks cell cycle progression in cervical cancer cell lines and regulates cell cycle-related genes, including restoration of p21 and p53 expression inducing apoptosis.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 12, 2021
    Applicant: University of South Carolina
    Inventors: Dev Karan, Mark T. Hamann
  • Publication number: 20190183040
    Abstract: A strand trimmer and method of use thereof. The strand trimmer includes a pair of pivotable arms each having a motor, a follower wheel, and a cutter-spindle assembly disposed thereon. The arms are biased toward one another and are guided by the follower wheels to pivot around obstacles passing between the arms. The motor rotates the cutter-spindle assembly to move cutting strands extending therefrom through a cutting path with sufficient rotational velocity to cut vegetation. The cutter-spindle assembly includes a reloadable spool and a strand-feed mechanism. The strand-feed mechanism includes a solenoid actuated plunger within a shaft of the cutter-spindle assembly which operates to non-contactingly actuate the plunger to feed out a length of strand. The solenoid is non-rotatably carried on the trimmer arm while the shaft of the cutter-spindle assembly is encircled by and rotated within the solenoid.
    Type: Application
    Filed: February 25, 2019
    Publication date: June 20, 2019
    Applicant: Trimverse LLC
    Inventors: Robert Simmons, Mark T. Hamann, Royce M. Peters
  • Patent number: 8633166
    Abstract: This present provides kaempferol-3-(2-E,3-Z-di-p-coumaroyl)-rhamnoside, kaempferol-3-(2-Z-3-E-di-p-coumaroyl)-rhamnoside, and kaempferol-3-(2,3-di-Z-p-coumaroyl)-rhamnoside compounds useful as a new class of anti-bacterial agents. These compounds are extracted from Platanus occidentalis. These compounds were found to exhibit anti-bacterial activity against methicillin resistant Staphylococcus aureus (MRSA).
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: January 21, 2014
    Inventors: Mark T. Hamann, Mohamed Ali
  • Patent number: 8268856
    Abstract: The sponges were collected from a variety of locations in the Florida Keys and separated based on morphology and color. The samples were identified as three species, two of which are well known: V. rigida (Esper, 1794) (order Verongida, family Aplysinidae) and S. aurea (Hyatt, 1875) (order Dictyoceratida, family Thorectidae), and a third S. cerebriformis (Duchassaing & Michelotti, 1864), is less common and separated based on subtle differences of morphology and coloration, from the other two species. Several compounds were isolated and were evaluated in established animal models predictive of neurological related drug function, namely, the rodent FST and the chick anxiety-depression model.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: September 18, 2012
    Inventors: Mark T. Hamann, Anna J. Kochanowska, Abir El-Alfy, Rae R. Matsumoto, Angelo Boujos
  • Publication number: 20120029010
    Abstract: The sponges were collected from a variety of locations in the Florida Keys and separated based on morphology and color. The samples were identified as three species, two of which are well known: V. rigida (Esper, 1794) (order Verongida, family Aplysinidae) and S. aurea (Hyatt, 1875) (order Dictyoceratida, family Thorectidae), and a third S. cerebriformis (Duchassaing & Michelotti, 1864), is less common and separated based on subtle differences of morphology and coloration, from the other two species. Several compounds were isolated and were evaluated in established animal models predictive of neurological related drug function, namely, the rodent FST and the chick anxiety-depression model.
    Type: Application
    Filed: October 5, 2011
    Publication date: February 2, 2012
    Inventors: Mark T. Hamann, Anna J. Kochanowska, Abir El-Alfy, Rae R. Matsumoto, Angelo Boujos
  • Publication number: 20100273726
    Abstract: This present provides kaempferol-3-(2-E,3-Z-di-p-coumaroyl)-rhamnoside, kaempferol-3-(2-Z-3-E-di-p-coumaroyl)-rhamnoside, and kaempferol-3-(2,3-di-Z-p-coumaroyl)-rhamnoside compounds useful as a new class of anti-bacterial agents. These compounds are extracted from Platanus occidentalis or Laurus nobilis. These compounds were found to exhibit anti-bacterial activity against methicillin resistant Staphylococcus aureus (MRSA).
    Type: Application
    Filed: April 27, 2010
    Publication date: October 28, 2010
    Applicant: TRITON BIOPHARMA
    Inventors: Mark T. Hamann, Mohamed A. Ibrahim
  • Publication number: 20100234311
    Abstract: This present provides kaempferol-3-(2-E,3-Z-di-p-coumaroyl)-rhamnoside, kaempferol-3-(2-Z-3-E-di-p-coumaroyl)-rhamnoside, and kaempferol-3-(2,3-di-Z-p-coumaroyl)-rhamnoside compounds useful as a new class of anti-bacterial agents. These compounds are extracted from Platanus occidentalis. These compounds were found to exhibit anti-bacterial activity against methicillin resistant Staphylococcus aureus (MRSA).
    Type: Application
    Filed: March 16, 2010
    Publication date: September 16, 2010
    Applicant: The University of Mississippi
    Inventors: Mark T. Hamann, Mohamed Ali
  • Publication number: 20090093513
    Abstract: The sponges were collected from a variety of locations in the Florida Keys and separated based on morphology and color. The samples were identified as three species, two of which are well known: V. rigida (Esper, 1794) (order Verongida, family Aplysinidae) and S. aurea (Hyatt, 1875) (order Dictyoceratida, family Thorectidae), and a third S. cerebriformis (Duchassaing & Michelotti, 1864), is less common and separated based on subtle differences of morphology and coloration, from the other two species. Several compounds were isolated and were evaluated in established animal models predictive of neurological related drug function, namely, the rodent FST and the chick anxiety-depression model.
    Type: Application
    Filed: October 9, 2008
    Publication date: April 9, 2009
    Inventors: Mark T. Hamann, Anna J. Kochanowska, Abir El-Alfy, Rae R. Matsumoto, Angelo Boujos
  • Patent number: 6900195
    Abstract: A method of treating an infectious disease or condition in a subject in need of such treatment is disclosed. The method comprises administering to a subject an effective amount of a manzamine, manzamine derivative or analog or an optical isomer or racemate or tautomer thereof or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 29, 2001
    Date of Patent: May 31, 2005
    Assignee: The University of Mississippi
    Inventors: Mark T. Hamann, Khalid El-Sayed
  • Publication number: 20040019029
    Abstract: A method of treating an infectious disease or condition in a subject in need of such treatment is disclosed. The method comprises administering to a subject an effective amount of a manzamine, manzamine derivative or analog or an optical isomer or racemate or tautomer thereof or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 22, 2003
    Publication date: January 29, 2004
    Inventors: Mark T. Hamann, Khalid El-Sayed
  • Patent number: 6274551
    Abstract: Kalahide F, of formula I below, may be isolated from a sacoglossan. The compound may be used in the manufacture of pharmaceutical compositions or in the treatment of tumors or viral conditions.
    Type: Grant
    Filed: February 3, 1994
    Date of Patent: August 14, 2001
    Assignee: PharmaMar, S.A.
    Inventors: Paul J Scheuer, Mark T Hamann, Dolores G. Gravalos
  • Patent number: 6011010
    Abstract: Kalahide F. of formula I below, may be isolated from a secoglossan. The compound may be used in the manufacture of pharmaceutical compositions or in the treatment of tumors or viral conditions.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: January 4, 2000
    Assignee: Pharma Mar, s.a.
    Inventors: Paul J Scheuer, Mark T Hamann, Dolores G. Gravalos
  • Patent number: RE39496
    Abstract: Kalahide Kahalalide F, of formula I below, may be isolated from a sacoglossan.
    Type: Grant
    Filed: August 14, 2003
    Date of Patent: February 27, 2007
    Assignee: PharmaMar, S.A.
    Inventors: Alice E. D. Scheuer, Mark T. Hamann, Dolores G. Gravalos, Paul J. Scheuer